Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Hromas

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
Blood Cancer Journal|November 28, 2017
Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemiaMaxim Norkin, Lakshmikanth Katragadda, Fei Zou, et al.
Cell Death Discovery|January 1, 2023
Co-targeting BCL-X<sub>L</sub> and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in miceSajid Khan, Patrick Kellish, Nick Connis, et al.
Molecular Cancer Therapeutics|October 20, 2021
Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-X<sub>L</sub>-Specific Degrader DT2216Dinesh Thummuri, Sajid Khan, Patrick W Underwood, et al.
Cell|April 18, 2025
CD36-mediated endocytosis of proteolysis-targeting chimerasZhengyu Wang, Bo-Syong Pan, Rajesh Kumar Manne, et al.
NAR Cancer|January 23, 2023
EEPD1 promotes repair of oxidatively-stressed replication forksAruna S Jaiswal, Hyun-Suk Kim, Orlando D Schärer, et al.
Nature|June 21, 2023
Structural insights into BCDX2 complex function in homologous recombinationYashpal Rawal, Lijia Jia, Aviv Meir, et al.
Cell Reports|May 5, 2025
Distinct roles of the two BRCA2 DNA-binding domains in DNA damage repair and replication fork preservationFrancisco E Neal, Wenjing Li, Mollie E Uhrig, et al.
Nucleic Acids Research|November 12, 2023
TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cellsAruna S Jaiswal, Arijit Dutta, Gayathri Srinivasan, et al.
Nature Communications|April 28, 2025
Epigenetic silencing of DNA sensing pathway by FOXM1 blocks stress ligand-dependent antitumor immunity and immune memorySantosh Timilsina, Jian Yu Huang, Nourhan Abdelfattah, et al.
JCO Precision Oncology|December 3, 2024
Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient NeoplasmsThomas J George, Ji-Hyun Lee, David L DeRemer, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Blood Cancer Journal|November 28, 2017
Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemiaMaxim Norkin, Lakshmikanth Katragadda, Fei Zou, et al.
Cell Death Discovery|January 1, 2023
Co-targeting BCL-X<sub>L</sub> and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in miceSajid Khan, Patrick Kellish, Nick Connis, et al.
Molecular Cancer Therapeutics|October 20, 2021
Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-X<sub>L</sub>-Specific Degrader DT2216Dinesh Thummuri, Sajid Khan, Patrick W Underwood, et al.
Cell|April 18, 2025
CD36-mediated endocytosis of proteolysis-targeting chimerasZhengyu Wang, Bo-Syong Pan, Rajesh Kumar Manne, et al.
NAR Cancer|January 23, 2023
EEPD1 promotes repair of oxidatively-stressed replication forksAruna S Jaiswal, Hyun-Suk Kim, Orlando D Schärer, et al.
Nature|June 21, 2023
Structural insights into BCDX2 complex function in homologous recombinationYashpal Rawal, Lijia Jia, Aviv Meir, et al.
Cell Reports|May 5, 2025
Distinct roles of the two BRCA2 DNA-binding domains in DNA damage repair and replication fork preservationFrancisco E Neal, Wenjing Li, Mollie E Uhrig, et al.
Nucleic Acids Research|November 12, 2023
TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cellsAruna S Jaiswal, Arijit Dutta, Gayathri Srinivasan, et al.
Nature Communications|April 28, 2025
Epigenetic silencing of DNA sensing pathway by FOXM1 blocks stress ligand-dependent antitumor immunity and immune memorySantosh Timilsina, Jian Yu Huang, Nourhan Abdelfattah, et al.
JCO Precision Oncology|December 3, 2024
Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient NeoplasmsThomas J George, Ji-Hyun Lee, David L DeRemer, et al.
Pageof 11